GlassScriptPhysician profile
Thomas G Benvenuti
NPI 1699708966
$11,453.30
in general payments reported to CMS, 2019-2025
49 companies · $2,191 in 2025
The $2,191 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,258 · 2020: $522 · 2021: $830 · 2022: $1,759 · 2023: $2,307 · 2024: $2,587 · 2025: $2,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,084.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,016.88 | 2021-2025 | |
| Pfizer INC. | $910.58 | 2019-2025 | |
| Amgen INC. | $843.46 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $795.18 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $698.36 | 2019-2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $647.45 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $643.47 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $538.12 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $526.64 | 2019-2025 | Farxiga, Wainua, Airsupra |
| Abbott Laboratories | $435.39 | 2019-2025 | Assurity, Aveir, Gallant |
| Boston Scientific Corporation | $414.31 | 2020-2025 | Watchman Flx, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $398.27 | 2022-2025 | Verquvo, Capvaxive |
| Amarin Pharma, INC. | $378.94 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $367.82 | 2019-2025 | Evkeeza |
| Impulse Dynamics (USA) INC. | $311.32 | 2022-2024 | Optimizer, Optimizer |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $247.62 | 2022-2025 | Assure Wcd |
| Heartflow, INC. | $192.20 | 2020-2024 | Ffrct |
| Shockwave Medical, INC | $158.96 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Scpharmaceuticals INC. | $143.15 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $120.85 | 2019-2023 | Opsumit, Uptravi |
| Otsuka America Pharmaceutical, INC. | $117.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $114.82 | 2019-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $108.47 | 2024 | Arcalyst |
| Medtronic, INC. | $104.76 | 2021-2023 | Linq II |
| Kiniksa Pharmaceuticals, LTD. | $98.30 | 2022-2023 | Arcalyst |
| Cmp Pharma, INC. | $96.78 | 2022-2023 | Norliqva, Tadliq, Carospir |
| Bayer Healthcare Pharmaceuticals INC. | $92.52 | 2022-2025 | |
| Recor Medical INC | $87.56 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Abiomed | $78.79 | 2022-2024 | Impella |
| Esperion Therapeutics, INC. | $78.22 | 2023-2025 | Nexletol |
| Cvrx, INC. | $76.86 | 2024-2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $71.59 | 2025 | Attruby |
| Portola Pharmaceuticals, LLC | $66.13 | 2019 | |
| Bardy Diagnostics, INC. | $52.83 | 2019-2022 | |
| Zoll Respicardia, INC. | $42.84 | 2024-2025 | Remede System |
| Baxter Healthcare | $42.52 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $41.22 | 2020 | |
| Novo Nordisk INC | $41.05 | 2024 | Wegovy, Ozempic |
| Zoll Circulation INC | $37.80 | 2020 | |
| Genzyme Corporation | $30.95 | 2024 | |
| Irhythm Technologies, INC. | $27.84 | 2024 | Zio Xt Patch, Zio Monitor |
| Cardiva Medical, INC. | $22.93 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $22.10 | 2020 | |
| Lilly USA, LLC | $21.95 | 2025 | Mounjaro, Zepbound |
| Lundbeck LLC | $21.42 | 2019 | |
| Cleerly, INC. | $18.75 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Cathworks, INC. | $16.94 | 2019 | |
| Sanofi Pasteur INC. | $16.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Benvenuti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.